---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-065842"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:24:51.075951+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma appoints Charles Parker as Interim CFO, effective July 5, 2025, replacing Nora Brennan

## Summary
- Nora Brennan resigns as Interim CFO effective July 5, 2025; no severance, will provide transition services as independent contractor through July 18.
- Board appoints Charles Parker as Interim CFO effective July 5; he is a Director at Stout, a global advisory firm.
- Parker has over two decades of biopharma finance experience, including $700M+ capital raises and multi-million dollar debt restructurings.
- Compensation terms for Parker not yet finalized; disclosure expected when consulting agreement is completed.

## SEC filing metadata
- accession: 0001104659-25-065842
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925065842/0001104659-25-065842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925065842/tm2519404d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-065842
- JSON: https://secwatch.observer/filing/0001104659-25-065842.json
- Plain text: https://secwatch.observer/filing/0001104659-25-065842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.